Antti Ropponen

480 total citations
24 papers, 382 citations indexed

About

Antti Ropponen is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Antti Ropponen has authored 24 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Immunology and 8 papers in Oncology. Recurrent topics in Antti Ropponen's work include Cell death mechanisms and regulation (8 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Antti Ropponen is often cited by papers focused on Cell death mechanisms and regulation (8 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Antti Ropponen collaborates with scholars based in Finland, Luxembourg and United States. Antti Ropponen's co-authors include Jukka Pelkonen, Mine Eray, Mikko Mättö, Jarmo Wahlfors, Riikka Pellinen, Marjo Malinen, Sami Vaïsänen, Carsten Carlberg, Tatjana Degenhardt and Anna Saramäki and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Antti Ropponen

24 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antti Ropponen Finland 12 192 118 89 77 70 24 382
Christine Rivat France 7 284 1.5× 143 1.2× 171 1.9× 26 0.3× 59 0.8× 7 503
Daniela Di Marcantonio United States 15 417 2.2× 49 0.4× 148 1.7× 86 1.1× 31 0.4× 29 569
Priscila Santos Scheucher Brazil 12 285 1.5× 64 0.5× 62 0.7× 101 1.3× 24 0.3× 41 488
Nicolas Papadopoulos Belgium 9 253 1.3× 85 0.7× 274 3.1× 55 0.7× 31 0.4× 17 455
Yael Morgenstern Israel 4 228 1.2× 87 0.7× 118 1.3× 21 0.3× 29 0.4× 9 364
Eva Ulbrich Germany 10 164 0.9× 80 0.7× 185 2.1× 24 0.3× 45 0.6× 11 432
Qing-Rong Chen United States 9 289 1.5× 31 0.3× 105 1.2× 30 0.4× 54 0.8× 9 484
Olesya Chayka United Kingdom 12 378 2.0× 93 0.8× 210 2.4× 23 0.3× 33 0.5× 17 571
Tom Büchse Germany 8 245 1.3× 161 1.4× 90 1.0× 97 1.3× 17 0.2× 10 446

Countries citing papers authored by Antti Ropponen

Since Specialization
Citations

This map shows the geographic impact of Antti Ropponen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antti Ropponen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antti Ropponen more than expected).

Fields of papers citing papers by Antti Ropponen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antti Ropponen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antti Ropponen. The network helps show where Antti Ropponen may publish in the future.

Co-authorship network of co-authors of Antti Ropponen

This figure shows the co-authorship network connecting the top 25 collaborators of Antti Ropponen. A scholar is included among the top collaborators of Antti Ropponen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antti Ropponen. Antti Ropponen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Partanen, Anu, Antti Ropponen, Outi Kuittinen, et al.. (2020). Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study. Leukemia & lymphoma. 61(9). 2082–2092. 11 indexed citations
2.
Partanen, Anu, Antti Ropponen, Kaija Vasala, et al.. (2017). Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly. Annals of Hematology. 96(11). 1897–1906. 7 indexed citations
3.
Varmavuo, Ville, Antti Ropponen, Tuomas Selander, et al.. (2016). Early immune recovery after autologous transplantation in non-Hodgkin lymphoma patients: predictive factors and clinical significance. Leukemia & lymphoma. 57(9). 2025–2032. 16 indexed citations
4.
5.
Ropponen, Antti, et al.. (2015). ERK1/2 has an essential role in B cell receptor- and CD40-induced signaling in an in vitro model of germinal center B cell selection. Molecular Immunology. 67(2). 240–247. 17 indexed citations
6.
Takabe, Piia, Geneviève Bart, Antti Ropponen, et al.. (2015). Hyaluronan synthase 3 (HAS3) overexpression downregulates MV3 melanoma cell proliferation, migration and adhesion. Experimental Cell Research. 337(1). 1–15. 23 indexed citations
7.
Ropponen, Antti, et al.. (2015). Rituximab-induced early and late signaling have opposite effects on dexamethasone-induced apoptosis in human follicular lymphoma cells. Leukemia & lymphoma. 56(8). 2448–2457. 2 indexed citations
8.
Varmavuo, Ville, Antti Ropponen, Anne Nihtinen, et al.. (2015). Blood graft cellular composition and posttransplant recovery in non‐Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison. Transfusion. 55(10). 2358–2368. 18 indexed citations
9.
Deen, Ashik Jawahar, Kirsi Rilla, Sanna Oikari, et al.. (2014). Rab10-mediated Endocytosis of the Hyaluronan Synthase HAS3 Regulates Hyaluronan Synthesis and Cell Adhesion to Collagen. Journal of Biological Chemistry. 289(12). 8375–8389. 27 indexed citations
10.
Ropponen, Antti, Mikko Mättö, Mine Eray, et al.. (2009). The involvement of mitochondria and the caspase-9 activation pathway in rituximab-induced apoptosis in FL cells. APOPTOSIS. 14(5). 687–698. 36 indexed citations
11.
Ropponen, Antti, et al.. (2009). Dexamethasone-induced apoptosis and up-regulation of Bim is dependent on glycogen synthase kinase-3. Leukemia Research. 33(12). 1714–1717. 22 indexed citations
12.
Ropponen, Antti, Mikko Mättö, Mine Eray, et al.. (2009). Feedback Regulation of Mitochondria by Caspase‐9 in the B Cell Receptor‐Mediated Apoptosis. Scandinavian Journal of Immunology. 70(6). 574–583. 11 indexed citations
13.
Makkonen, Katri M., Marjo Malinen, Antti Ropponen, Sami Vaïsänen, & Carsten Carlberg. (2009). Cell Cycle Regulatory Effects of Retinoic Acid and Forskolin Are Mediated by the Cyclin C Gene. Journal of Molecular Biology. 393(2). 261–271. 8 indexed citations
14.
Ropponen, Antti, et al.. (2009). The Effect of Microenvironmental CD40 Signals on TRAIL‐ and Drug‐induced Apoptosis in Follicular Lymphoma Cells. Scandinavian Journal of Immunology. 70(6). 565–573. 6 indexed citations
15.
Ropponen, Antti, Mikko Mättö, Mine Eray, et al.. (2008). PDTC enables type I TRAIL signaling in type II follicular lymphoma cells. Leukemia Research. 33(6). 829–836. 11 indexed citations
16.
Malinen, Marjo, Anna Saramäki, Antti Ropponen, et al.. (2007). Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to trichostatin A and 1α,25-dihydroxyvitamin D 3. Nucleic Acids Research. 36(1). 121–132. 52 indexed citations
17.
Ropponen, Antti, et al.. (2006). The CD40-induced protection against CD95-mediated apoptosis is associated with a rapid upregulation of anti-apoptotic c-FLIP. Molecular Immunology. 44(6). 1230–1237. 10 indexed citations
18.
Mättö, Mikko, et al.. (2005). Inhibition of PI3-kinase–Akt pathway enhances dexamethasone-induced apoptosis in a human follicular lymphoma cell line. Experimental Cell Research. 312(3). 322–30. 35 indexed citations
19.
Mättö, Mikko, et al.. (2005). CD45RA and RO Isoforms Have Distinct Effects on Cytokine‐ and B‐Cell‐Receptor‐Mediated Signalling in Human B cells. Scandinavian Journal of Immunology. 61(6). 520–528. 12 indexed citations
20.
Mättö, Mikko, et al.. (2003). Kinetics and signaling requirements of CD40‐mediated protection from B cell receptor‐induced apoptosis. European Journal of Immunology. 33(10). 2783–2791. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Rivat Breakdown of academic impact, for papers by Daniela Di Marcantonio Breakdown of academic impact, for papers by Priscila Santos Scheucher Breakdown of academic impact, for papers by Nicolas Papadopoulos Breakdown of academic impact, for papers by Yael Morgenstern Breakdown of academic impact, for papers by Eva Ulbrich Breakdown of academic impact, for papers by Qing-Rong Chen Breakdown of academic impact, for papers by Olesya Chayka Breakdown of academic impact, for papers by Tom Büchse
Rankless by CCL
2026